Thymol (5-methyl-2-(propan-2-yl)phenol)
Thymol (5-methyl-2-(propan-2-yl)phenol) is a naturally occurring monoterpene phenol found in thyme (Thymus vulgaris) and other aromatic plants, where it functions as the primary bioactive constituent responsible for antimicrobial and antioxidant activity. It exerts its effects primarily by disrupting microbial cell membrane integrity and inhibiting lipid peroxidation through free radical scavenging.
Origin & History
Thymol (5-methyl-2-(propan-2-yl)phenol) is a naturally occurring monoterpene phenol primarily found in thyme (Thymus vulgaris) essential oil, as well as oregano and ajwain. It is extracted as white crystals via hydro-distillation (4.5 hours) or solvent-free microwave extraction (30 minutes), and can be synthesized industrially by alkylating m-cresol with propene.
Historical & Cultural Context
No information on traditional medicine use, historical context, or traditional indications for thymol is provided in the research dossier.
Health Benefits
• No clinical health benefits documented - research focuses only on extraction methods • No human trials available in provided research • Only analytical detection methods described • No therapeutic effects studied in humans • Evidence limited to chemical characterization
How It Works
Thymol disrupts bacterial and fungal cell membranes by integrating into the phospholipid bilayer, increasing membrane permeability and causing leakage of intracellular contents including potassium ions and ATP. It inhibits bacterial enzymes such as urease and α-glucosidase, and suppresses microbial biofilm formation by downregulating quorum-sensing gene expression. As an antioxidant, thymol scavenges reactive oxygen species and chelates transition metal ions, reducing lipid peroxidation chain reactions mediated by hydroxyl and peroxyl radicals.
Scientific Research
The research dossier contains no human clinical trials, RCTs, or meta-analyses for thymol. Available sources focus exclusively on analytical methods for detecting thymol in formulations rather than clinical outcomes, with no PubMed PMIDs for human studies provided.
Clinical Summary
Human clinical trials specifically isolating thymol as a standalone supplement do not currently exist in the published literature; most evidence derives from in vitro cell studies and animal models. Laboratory studies demonstrate minimum inhibitory concentrations (MICs) of 0.125–0.5 mg/mL against common pathogens including Staphylococcus aureus and Candida albicans, though these concentrations have not been validated in human pharmacokinetic contexts. Thymol is an active component in thyme-based oral rinse formulations (e.g., Listerine at ~0.064% concentration) that have clinical support for reducing gingivitis and plaque, but isolating thymol's individual contribution remains methodologically unconfirmed. Overall evidence strength for thymol as an isolated therapeutic agent in humans is very low, categorized as preclinical.
Nutritional Profile
Thymol (5-methyl-2-(propan-2-yl)phenol) is a pure monoterpenoid phenol compound (C10H14O, molecular weight 150.22 g/mol), not a food or nutritional source. As a single isolated bioactive compound, it contains no macronutrients (zero protein, carbohydrates, or fat in functional context), no dietary fiber, no vitamins, and no minerals. The compound itself IS the bioactive constituent: a monoterpene phenol comprising an isopropyl group and methyl group on a phenolic ring. It is the primary active constituent found in thyme (Thymus vulgaris) essential oil at concentrations of 20–55% of total oil composition, and in oregano oil at 5–15%. In its pure isolated form, thymol has a melting point of 49–51°C, is sparingly soluble in water (~1 g/L at 20°C) but highly soluble in ethanol and lipids, which directly impacts its bioavailability — lipid-based delivery systems significantly enhance absorption. Key chemical properties relevant to bioactivity include its phenolic hydroxyl group (responsible for antimicrobial and antioxidant activity) and its lipophilic character (logP ≈ 3.3), facilitating membrane penetration. No caloric or nutritional value is assigned as it is used in trace/therapeutic concentrations (typically 0.1–1.0% in formulations), not as a dietary macronutrient source.
Preparation & Dosage
No clinically studied dosage ranges are available in the research. The sources emphasize extraction and synthesis methods without human trial data. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Insufficient data for synergistic combinations
Safety & Interactions
Thymol is generally recognized as safe (GRAS) by the FDA when used in food flavoring at typical dietary concentrations, but concentrated supplemental doses can cause oral mucosa irritation, nausea, vomiting, and gastrointestinal discomfort. High-dose ingestion has been associated with rare cases of systemic toxicity including dizziness, cardiac depression, and respiratory distress in animal models, suggesting caution with concentrated oral supplements. Thymol may potentiate anticoagulant medications such as warfarin by inhibiting platelet aggregation, and may interact with CYP450 enzymes (particularly CYP2C9 and CYP3A4), potentially altering the metabolism of co-administered drugs. Thymol is not recommended during pregnancy or breastfeeding in supplemental doses due to insufficient safety data and evidence of uterine-stimulating activity observed in preclinical studies.